NASDAQ:ALPN
Alpine Immune Sciences, Inc.
- Stock
Last Close
64.96
17/05 20:00
Market Cap
4.46B
Beta: 1.26
Volume Today
4.29M
Avg: 76.25K
PE Ratio
−24.74
PFCF: −20.65
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 1.73M - | 705K 59.27% | 1.74M 146.81% | 9.34M 436.49% | 23.44M 151.13% | 30.06M 28.24% | 58.88M 95.84% | ||||
cost of revenue | |||||||||||
gross profit | 1.73M - | 705K 59.27% | 1.74M 146.81% | 9.34M 436.49% | 23.44M 151.13% | 30.06M 28.24% | 58.88M 95.84% | ||||
selling and marketing expenses | |||||||||||
general and administrative expenses | 2.29M - | 6.84M 199.16% | 8.59M 25.45% | 6.08M 29.20% | 8.36M 37.56% | 9.47M 13.21% | 10.90M 15.13% | 14.56M 33.59% | 17.97M 23.41% | 22.22M 23.68% | |
selling general and administrative expenses | 2.29M - | 6.84M 199.16% | 8.59M 25.45% | 6.08M 29.20% | 8.36M 37.56% | 9.47M 13.21% | 10.90M 15.13% | 14.56M 33.59% | 17.97M 23.41% | 22.22M 23.68% | |
research and development expenses | 12.20M - | 16.05M 31.60% | 23.32M 45.23% | 10.63M 54.43% | 28.97M 172.63% | 35.85M 23.74% | 27.18M 24.16% | 58.74M 116.08% | 70.24M 19.58% | 80.90M 15.18% | |
other expenses | 296.34K - | 80K 73.00% | 1.20M - | 812K 32.50% | 1.33M 64.16% | -4K 100.30% | -97K 2,325% | ||||
cost and expenses | 14.49M - | 22.90M 58.06% | 31.90M 39.32% | 16.70M 47.64% | 37.33M 123.48% | 45.31M 21.38% | 38.08M 15.96% | 73.30M 92.47% | 88.21M 20.34% | 103.13M 16.91% | |
operating expenses | 14.49M - | 22.90M 58.06% | 31.90M 39.32% | 16.70M 47.64% | 37.33M 123.48% | 45.31M 21.38% | 38.08M 15.96% | 73.30M 92.47% | 88.21M 20.34% | 103.13M 16.91% | |
interest expense | 845.10K - | 152K - | 319K 109.87% | 338K 5.96% | 775K 129.29% | 816K 5.29% | 476K 41.67% | -98K 120.59% | |||
ebitda | -14.10M - | -22.90M 62.35% | -31.90M 39.32% | -14.19M 55.52% | -35.33M 148.97% | -41.51M 17.50% | -27.17M 34.55% | -49.60M 82.56% | -54.96M 10.79% | -44.25M 19.48% | |
operating income | -14.49M - | -22.90M 58.06% | -31.90M 39.32% | -14.97M 53.06% | -37.83M 152.64% | -43.57M 15.18% | -28.75M 34.02% | -49.86M 73.43% | -58.15M 16.62% | -44.25M 23.90% | |
depreciation and amortization | 86.44K - | 66K 23.65% | 143K 116.67% | 241K 68.53% | 388K 61.00% | 2.06M 430.93% | 1.58M 23.40% | 255K 83.84% | 3.19M 1,151.37% | ||
total other income expenses net | 296.34K - | 80K 73.00% | 439K 448.75% | 6.60M 1,403.64% | -1.20M 118.22% | 1.72M 243.14% | 803K 53.37% | -561K 169.86% | 2.71M 583.96% | 11.96M 340.63% | |
income before tax | -15.04M - | -22.82M 51.76% | -31.46M 37.89% | -7.98M 74.63% | -36.85M 361.64% | -41.85M 13.56% | -27.95M 33.23% | -50.42M 80.42% | -55.43M 9.94% | -32.29M 41.75% | |
income tax expense | 1.14M - | -66K 105.78% | -143K 116.67% | -200K 39.86% | -366K 83% | 682K 286.34% | -6K 100.88% | -87K 1,350% | 2.33M 2,778.16% | -103K 104.42% | |
net income | -15.04M - | -22.82M 51.76% | -31.46M 37.89% | -7.78M 75.26% | -36.49M 368.80% | -42.53M 16.57% | -27.94M 34.31% | -50.33M 80.15% | -57.76M 14.76% | -32.18M 44.28% | |
weighted average shs out | 2.28M - | 2.34M 2.70% | 3.87M 65.32% | 6.48M 67.36% | 13.85M 113.67% | 18.36M 32.56% | 20.83M 13.44% | 25.48M 22.33% | 33.44M 31.24% | 50.00B 149,443.65% | |
weighted average shs out dil | 2.28M - | 2.34M 2.70% | 3.87M 65.32% | 6.48M 67.36% | 13.85M 113.67% | 18.36M 32.56% | 20.83M 13.44% | 25.48M 22.33% | 33.44M 31.24% | 50.00B 149,443.65% | |
eps | -6.59 - | -9.74 47.80% | -8.12 16.63% | -1.20 85.22% | -2.63 119.17% | -2.32 11.79% | -1.34 42.24% | -1.98 47.76% | -1.73 12.63% | -0.00 99.97% | |
epsdiluted | -6.59 - | -9.74 47.80% | -8.12 16.63% | -1.20 85.22% | -2.63 119.17% | -2.32 11.79% | -1.34 42.24% | -1.98 47.76% | -1.73 12.63% | -0.00 99.97% |
All numbers in USD (except ratios and percentages)